Edition:
India

AB Science SA (ABS.PA)

ABS.PA on Paris Stock Exchange

9.08EUR
30 Oct 2020
Change (% chg)

€-0.15 (-1.63%)
Prev Close
€9.23
Open
€9.06
Day's High
€9.38
Day's Low
€9.00
Volume
81,161
Avg. Vol
176,400
52-wk High
€13.78
52-wk Low
€3.22

Select another date:

Wed, Jul 8 2020

BRIEF-AB Science: Publication Of New Results With Masitinib

* AB SCIENCE ANNOUNCES THAT NEW RESULTS PUBLISHED IN THE PEER-REVIEWED JOURNAL OF ALZHEIMER'S DISEASE SUPPORT MASITINIB'S POTENTIAL MODE OF ACTION IN ALZHEIMER'S DISEASE

BRIEF-AB Science Postpones AGM To No Later Than September 30

* ANNOUNCES THE POSTPONEMENT OF ITS ANNUAL GENERAL SHAREHOLDERS’ MEETING

BRIEF-AB Science Granted Authorization By ANSM To Initiate Phase 2 Study Evaluating Masitinib In Combination With Isoquercetin For The Treatment Of Covid-19

* AB SCIENCE GRANTED AUTHORIZATION BY ANSM TO INITIATE PHASE 2 STUDY EVALUATING MASITINIB IN COMBINATION WITH ISOQUERCETIN FOR THE TREATMENT OF COVID-19 Source text for Eikon: Further company coverage:

BRIEF-AB Science Initiates Phase 2 Study Evaluating Masitinib In Combination With Isoquercetin For Treatment Of COVID-19

* REG-AB SCIENCE GRANTED AUTHORIZATION BY ANSM TO INITIATE PHASE 2 STUDY EVALUATING MASITINIB IN COMBINATION WITH ISOQUERCETIN FOR THE TREATMENT OF COVID-19

Select another date: